In Vitro Activities of Tigecycline against Erythromycin-Resistant Streptococcus pyogenes and Streptococcus agalactiae : Mechanisms of Macrolide and Tetracycline Resistance
Open Access
- 1 January 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (1) , 323-325
- https://doi.org/10.1128/aac.48.1.323-325.2004
Abstract
The activity of tigecycline was tested against erythromycin-resistant streptococci (107 Streptococcus pyogenes and 98 Streptococcus agalactiae strains). The presence of erythromycin and tetracycline resistance genes was determined by PCR. Among S. pyogenes strains the most prevalent gene was mef (A) (91.6%). The erm (B) gene was the most prevalent (65.3%) among S. agalactiae strains. Tigecycline proved to be very active against all the isolates tested (MIC at which 90% of the isolates tested were inhibited, 0.06 μg/ml), including those resistant to tetracycline.Keywords
This publication has 18 references indexed in Scilit:
- Erythromycin and Clindamycin Resistance and Telithromycin Susceptibility in Streptococcus agalactiaeAntimicrobial Agents and Chemotherapy, 2003
- Genetic Basis of Antibiotic Resistance in Streptococcus agalactiae Strains Isolated in a French HospitalAntimicrobial Agents and Chemotherapy, 2003
- Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin.Journal of Antimicrobial Chemotherapy, 2002
- ReplyJournal of Antimicrobial Chemotherapy, 2002
- In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in SpainAntimicrobial Agents and Chemotherapy, 2002
- GAR-936 (9-t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteriaInternational Journal of Antimicrobial Agents, 2001
- Emerging erythromycin resistance among group B streptococci in Korea.European Journal of Clinical Microbiology & Infectious Diseases, 2001
- Resistance ofStreptococcus pyogenesto Erythromycin and Related Antibiotics in ItalyClinical Infectious Diseases, 1998
- Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in FinlandJournal of Antimicrobial Chemotherapy, 1993